2020
DOI: 10.1016/j.athoracsur.2019.11.059
|View full text |Cite
|
Sign up to set email alerts
|

Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
22
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 27 publications
(26 citation statements)
references
References 25 publications
4
22
0
Order By: Relevance
“…We examined the impact from several social determinants on timely surgery and whether the examined social determinants could explain the observed racial disparity. Unsurprisingly, private insurance was a significant predictor of the receipt of timely surgery or guideline-concordant care in lung cancer patients (17). Medicaid insured patients tended to experience the largest delay in receiving treatment (17).…”
Section: Discussionmentioning
confidence: 96%
See 3 more Smart Citations
“…We examined the impact from several social determinants on timely surgery and whether the examined social determinants could explain the observed racial disparity. Unsurprisingly, private insurance was a significant predictor of the receipt of timely surgery or guideline-concordant care in lung cancer patients (17). Medicaid insured patients tended to experience the largest delay in receiving treatment (17).…”
Section: Discussionmentioning
confidence: 96%
“…Unsurprisingly, private insurance was a significant predictor of the receipt of timely surgery or guideline-concordant care in lung cancer patients (17). Medicaid insured patients tended to experience the largest delay in receiving treatment (17). In a national study, compared to NSCLC patients with private insurance, the diagnosis-to-surgery interval was 2.3 days longer for Medicare patients, 10.8 days longer for Medicaid patients, and 7.8 days for longer for patients who were uninsured or whose insurance status was unknown (9).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In addition, several studies have described disparities in the use of LDCT screening in underserved populations, including racial/ethnic minorities (11,12), those living in rural areas with more limited access to care (13), and other vulnerable populations (14,15). Efforts to understand disparities in LDCT screening and their contributing factors have become increasingly relevant, as previous studies have shown that these same underserved populations have a greater incidence of lung cancer and are less likely to receive appropriate treatment (16)(17)(18)(19). Therefore, the objective of the present narrative review is to discuss lung cancer screening disparities in underserved populations and to examine methods of improving access to lung cancer screening in these patients.…”
Section: Review Articlementioning
confidence: 99%